- Article metrics
- Last updated: Thu, 9 Oct 2025 19:39:35 Z
CLR01 protects dopaminergic neurons in vitro and in mouse models of Parkinson’s disease
Access & Citations
-
- 14k
- Article Accesses
-
- 64
- Citations
Citation counts are provided by Dimensions and depend on their data availability. Counts will update daily, once available.
Online attention
- 48 tweeters
- 4 blogs
- 4 news outlets
- 121 Mendeley
This article is in the 96th percentile (ranked 17,202nd) of the 441,982 tracked articles of a similar age in all journals and the 78th percentile (ranked 339th) of the 1,584 tracked articles of a similar age in Nature Communications
View more on Altmetric
Altmetric calculates a score based on the online attention an article receives. Each coloured thread in the circle represents a different type of online attention. The number in the centre is the Altmetric score. Social media and mainstream news media are the main sources that calculate the score. Reference managers such as Mendeley are also tracked but do not contribute to the score. Older articles often score higher because they have had more time to get noticed. To account for this, Altmetric has included the context data for other articles of a similar age.
Mentions in news and blogs
-
Promising “molecular tweezer” Parkinson’s therapy looks to human trials
Gizmag Emerging Technology Magazine -
El papel de los astrocitos en la aparición de la enfermedad de Parkinson
Cuaderno de Cultura Científica -
The subcellular localization of CLR01, a drug candidate for proteinopathies, provides a major clue for its high potency in vivo
Nature Research Bioengineering Community
This list highlights individual mainstream news articles and blogs that cite the article. Not all news and blogs link to articles in a way that Altmetric can pick up, so they are not representative of all media. Altmetric are responsible for the curation of this list and provide updates hourly.